Clinical Trials

We are committed to supporting biomedical research endeavors to improve rheumatic and autoimmune disease outcomes. Led by Dr. Bobby Han, we partner with practicing physicians and industry sponsors to conduct health-related interventional and observational studies.

This is unpublished

Currently Enrolling

Disease Indication Study Information

Immune-Checkpoint Inhibitor-Induced Arthritis

Synovial Tissue and Peripheral Blood Phenotypes in Immune Checkpoint Inhibitor–Induced Arthritis

Still’s Disease with Macrophage Activation Syndrome

NI-0501-14: A Two-Cohort, Open-Label, Single Arm, Multicenter Study to Evaluate Efficacy, Safety and Tolerability, Pharmacokinetics and Pharmacodynamics, of Emapalumab in Children and Adults with Macrophage Activation Syndrome (MAS) in Still’s Disease or With MAS in Systemic Lupus Erythematous

Active Inflammatory Arthritis

Development and Validation of Applying Thermal Imaging as An Adjunct Tool to Augment Physician’s Assessment in The Telehealth Setting

System Lupus Erythematosus

SL0043: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants with Moderately to Severely Active Systemic Lupus Erythematosus



CUDM001: An Open-Label Pilot Study to Evaluate the Efficacy and Safety of Baricitinib in Subjects with Cutaneous Dermatomyositis

Open to All

Rheumatic Disease Biorepository & Patient Registry

Upcoming Study Areas

Stay tuned for more information on upcoming studies for Systemic Lupus Erythematosus, Rheumatoid Arthritis, Giant Cell Arteritis, Lupus Nephritis, Psoriatic Arthritis and Scleroderma.

Contact Us

Connect with the team via email or call to speak with our Research Manager.


Phone: 206-616-5330

If you have questions, are interested in participating, or want to sponsor a study at our site, let us know!